These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 730830)

  • 1. Differentiation of Bacteroides fragilis species by gas chromatographic detection of phenylacetic acid.
    van Assche PF
    J Clin Microbiol; 1978 Nov; 8(5):614-5. PubMed ID: 730830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid differentiation of the species of the genus Bacteroides sensu stricto by capillary gas chromatography of cellular carbohydrates.
    Engelhard E; Mutters R
    J Appl Bacteriol; 1991 Mar; 70(3):216-20. PubMed ID: 2030096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Bacteroides fragilis by indirect immunofluorescence.
    Weintraub A; Lindberg AA; Nord CE
    Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
    Blazevic DJ
    Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.
    Tong J; Liu C; Summanen P; Xu H; Finegold SM
    Anaerobe; 2011 Apr; 17(2):64-8. PubMed ID: 21439390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsular and 'O' serotype determinants of bacteroides fragilis.
    Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
    Infection; 1982; 10(6):333-7. PubMed ID: 6185437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated strains of Bacteroides fragilis in clinical specimens.
    Lindberg AA; Berthold P; Nord CE; Weintraub A
    Med Microbiol Immunol; 1979 Mar; 167(1):29-36. PubMed ID: 440201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):247-53. PubMed ID: 3956142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans].
    Chmelar D; Vrtný J
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):97-102. PubMed ID: 20640988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of the bacterial steroid degradation for the etiology of large bowel cancer. V. Transformation of chenodeoxycholic acid by saccharolytic bacteroides-species (author's transl)].
    Edenharder R; Stubenrauch S; Slemrova J
    Zentralbl Bakteriol Orig B; 1976 Aug; 162(5-6):506-18. PubMed ID: 983545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting production of catalase by Bacteroides.
    Wilkins TD; Wagner DL; Veltri BJ; Gregory EM
    J Clin Microbiol; 1978 Nov; 8(5):553-7. PubMed ID: 730827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein.
    Russell WR; Duncan SH; Scobbie L; Duncan G; Cantlay L; Calder AG; Anderson SE; Flint HJ
    Mol Nutr Food Res; 2013 Mar; 57(3):523-35. PubMed ID: 23349065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers.
    Liu C; Song Y; McTeague M; Vu AW; Wexler H; Finegold SM
    FEMS Microbiol Lett; 2003 May; 222(1):9-16. PubMed ID: 12757940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.
    Jenkins SG; Birk RJ; Zabransky RJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):628-34. PubMed ID: 7181473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification of clinically important bacteroides by coagglutination method.
    Lalitha MK; Anandi V; Elias L; Kalpana CR
    Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
    Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolation and identification of Bacteroides spp. from the normal human faecal flora.
    Duerden BI
    J Med Microbiol; 1980 Feb; 13(1):69-78. PubMed ID: 6102157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains.
    Wollenweber HW; Rietschel ET; Hofstad T; Weintraub A; Lindberg AA
    J Bacteriol; 1980 Dec; 144(3):898-903. PubMed ID: 7440508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.